Previous close | 436.74 |
Open | 438.90 |
Bid | 441.27 x 100 |
Ask | 441.64 x 100 |
Day's range | 432.87 - 446.11 |
52-week range | 254.85 - 468.78 |
Volume | |
Avg. volume | 1,436,029 |
Market cap | 156.818B |
Beta (5Y monthly) | 1.39 |
PE ratio (TTM) | 75.69 |
EPS (TTM) | 5.83 |
Earnings date | 17 Oct 2024 - 21 Oct 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 470.05 |
The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Align Technology's (ALGN) records second-quarter 2024 revenue growth across all regions. This was mostly due to a robust performance by the Imaging Systems & CAD/CAM Services business segment.
SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that Intuitive President David J. Rosa has been appointed to the Company’s Board of Directors, effective July 24, 2024. Rosa joins Intuitive CEO Gary S. Guthart, PhD, as one of two Intuitive executives on the Company’s Board. As president, Rosa manages Intuitive’s core business operations, which is balance